SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002254
Filing Date
2021-03-02
Accepted
2021-03-02 16:05:15
Documents
90
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20201231x10k.htm   iXBRL 10-K 3185758
2 EX-23.1 rigl-20201231xex23d1.htm EX-23.1 13723
3 EX-31.1 rigl-20201231xex31d1.htm EX-31.1 14879
4 EX-31.2 rigl-20201231xex31d2.htm EX-31.2 14924
5 EX-32.1 rigl-20201231xex32d1.htm EX-32.1 8708
6 GRAPHIC rigl-20201231x10k003.jpg GRAPHIC 78553
7 GRAPHIC rigl-20201231x10k004.jpg GRAPHIC 29689
  Complete submission text file 0001558370-21-002254.txt   12017875

Data Files

Seq Description Document Type Size
8 EX-101.SCH rigl-20201231.xsd EX-101.SCH 72648
9 EX-101.CAL rigl-20201231_cal.xml EX-101.CAL 65446
10 EX-101.DEF rigl-20201231_def.xml EX-101.DEF 261580
11 EX-101.LAB rigl-20201231_lab.xml EX-101.LAB 690555
12 EX-101.PRE rigl-20201231_pre.xml EX-101.PRE 491310
13 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20201231x10k_htm.xml XML 2344395
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 21703514
SIC: 2834 Pharmaceutical Preparations